“clinical-trials” Archives

in
Entry Author Date Location
Facing Cash Crunch, Novan Slashes Staff and Shuffles Executive Team 06/05/17 Raleigh Durham
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters 06/02/17 Indiana
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Array Lands $31M in Licensing Deal with Japan’s Ono Pharma 06/01/17 Boulder/Denver
Bicycle Therapeutics Maps Course to Clinic Backed by $52M Investment 06/01/17 Boston
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug 05/30/17 San Francisco
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Unconventional Partners, Like FDA, Can Drive Adoption of New Tech 05/24/17 Boston
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product 05/23/17 San Diego
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
Radius Shares Jump as Amgen’s Bone Drug Suffers a Setback in Phase 3 05/22/17 San Francisco
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
Ionis Touts Phase 3 Win, But Safety Worries Cloud Nerve Drug Study 05/15/17 San Diego
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Agro Bio, BrightStar, Stratatech, & More: This Week’s WI Watchlist 05/10/17 Wisconsin
Analysts Expect Payer Pushback as PTC Sets $35K Price For Duchenne Drug 05/08/17 New York
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data 05/04/17 Boston
Pieris Adds Another Partner, Gets $45M in AstraZeneca Lung Drug Deal 05/03/17 Boston
Shire Sets Sights on Dry Eye Disease with Deal for Parion Drug 05/01/17 Boston
FDA Wants More Safety Info on Psych Drug, Intra-Cellular Shares Drop 05/01/17 New York
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
After Sarepta’s Surprising FDA Nod, CEO Kaye Plans to Resign 04/28/17 Boston
Page 2 of 25 « previous page · next page »